Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

著者: Jie Jin, Jianxiang Wang, Feifei Chen, Depei Wu, Jiong Hu, Jianfeng Zhou, Jianda Hu, Jianmin Wang, Jianyong Li, Xiao‐Jun Huang, Jun Ma, Chunyan Ji, Xiaoping Xu, Kang Yu, Hanyun Ren, Yuhong Zhou, Yin Tong, Yinjun Lou, Wanmao Ni, Hongyan Tong, Huafeng Wang, Yingchang Mi, Xin Du, Baoan Chen, Yi Shen, Chen Zhu, Sai‐Juan Chen - The Lancet 2013 被引用: 160